Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/16300Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zikopoulos, K. A. | en |
| dc.contributor.author | Papanikolaou, E. G. | en |
| dc.contributor.author | Kalantaridou, S. N. | en |
| dc.contributor.author | Tsanadis, G. D. | en |
| dc.contributor.author | Plachouras, N. I. | en |
| dc.contributor.author | Dalkalitsis, N. A. | en |
| dc.contributor.author | Paraskevaidis, E. A. | en |
| dc.date.accessioned | 2015-11-24T18:29:48Z | - |
| dc.date.available | 2015-11-24T18:29:48Z | - |
| dc.identifier.issn | 0268-1161 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/16300 | - |
| dc.rights | Default Licence | - |
| dc.subject | abortion | en |
| dc.subject | misoprostol | en |
| dc.subject | medical pregnancy termination | en |
| dc.subject | early medical abortion | en |
| dc.subject | mifepristone ru-486 | en |
| dc.subject | illegal abortion | en |
| dc.subject | randomized trial | en |
| dc.subject | mu-g | en |
| dc.subject | methotrexate | en |
| dc.subject | efficacy | en |
| dc.subject | experience | en |
| dc.subject | brazil | en |
| dc.title | Early pregnancy termination with vaginal misoprostol before and after 42 days gestation | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | <Go to ISI>://000179839800012 | - |
| heal.identifier.secondary | http://humrep.oxfordjournals.org/content/17/12/3079.full.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών και Τεχνολογιών. Τμήμα Βιολογικών Εφαρμογών και Τεχνολογιών | el |
| heal.publicationDate | 2002 | - |
| heal.abstract | Background: Misoprostol is a prostaglandin El analogue that has been used for medical abortion. We conducted this prospective study to compare the efficacy of vaginal misoprostol for abortion in women at a gestational age of <42 days and in women at a gestational age of 42-56 days. Methods: A total of 160 women seeking medical termination of a pregnancy of <56 days were enrolled in the study. Medical termination was performed using 800 mug of vaginal misoprostol, repeated every 24 h for a maximum of three doses. Results: The overall complete abortion rate was 91.3%. In group A (gestation <42 days) complete abortion occurred in 96.3% of women, whereas in group B (gestation=42-56 days) complete abortion occurred in 86.3% of women (P<0.025). The two groups did not differ significantly with respect to side-effects (incidence of pain, bleeding, nausea, diarrhoea, fever and headache). Women who had aborted successfully were significantly more satisfied with the method compared with women who did not (P<0.001). Conclusions: The vaginal misoprostol-alone regimen is highly effective for women seeking medical abortion of pregnancies of &LE;56 days. However, better efficacy may be achieved at a gestational age of <42 days. | en |
| heal.journalName | Human Reproduction | en |
| heal.journalType | peer reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Zikopoulos-2002-Early pregnancy term.pdf | 66.98 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
